{"a":[{"_":"Ultragenyx, after FDA speed bump, lands 1st gene therapy nod with green light in glycogen storage disease","$":{"href":"/pharma/ultragenyx-after-fda-speed-bump-lands-1st-gene-therapy-nod-green-light-glycogen-storage","hreflang":"en"}}]}
RegulatoryapprovedPositive
AI Analysis
Summary
Ultragenyx received its first FDA approval for a gene therapy targeting glycogen storage disease, marking a milestone following a previous program that faced manufacturing setbacks.
Outcome Details
First FDA approval in gene therapy class for glycogen storage disease treatment
Importance:8/10
Sentiment:
0.85
gene therapyFDA approvalglycogen storage diseasefirst approval
Related Companies
Read the original article
Published by FiercePharma on August 19, 2026 10:36 PM